These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35180149)
1. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma: Analysis of the National Inpatient Sample From 2007 to 2014. Bodek DD; Everwine MM; Lunsford KE; Okoronkwo N; Patel PA; Pyrsopoulos N J Clin Gastroenterol; 2023 Mar; 57(3):311-316. PubMed ID: 35180149 [TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update. Kilani Y; Kamal SAF; Vikash F; Vikash S; Aldiabat M; Alsakarneh S; Aljabiri Y; Sohail H; Kumar V; Numan L; Al Khalloufi K Dig Dis Sci; 2023 Oct; 68(10):4050-4059. PubMed ID: 37584869 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database. Lam PH; Obirieze AC; Ortega G; Nwokeabia I; Onyewu S; Purnell SD; Samimi MM; Weeks CB; Lee EL; Shokrani B; Frederick WA; Callender CO; Wilson LL Transplant Proc; 2016; 48(1):123-7. PubMed ID: 26915856 [TBL] [Abstract][Full Text] [Related]
4. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441 [TBL] [Abstract][Full Text] [Related]
5. Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma. Sarpel U; Suprun M; Sofianou A; Berger Y; Tedjasukmana A; Sekendiz Z; Bagiella E; Schwartz ME Clin Transplant; 2016 Jun; 30(6):714-21. PubMed ID: 27027869 [TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States. Rajbhandari R; Simon RE; Chung RT; Ananthakrishnan AN Mayo Clin Proc; 2016 Sep; 91(9):1173-82. PubMed ID: 27497857 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. Gutin L; Yao F; Dodge JL; Grab J; Mehta N JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395 [TBL] [Abstract][Full Text] [Related]
8. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma. Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167 [TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289 [TBL] [Abstract][Full Text] [Related]
10. Racial and ethnic disparities in heart transplantation for end-stage heart failure: An analysis of the national inpatient sample (NIS) database. Ismail MF; Abughazaleh S; Obeidat O; Alzghoul H; Bodla ZH; Al-Ani H; Al-Ani M; Tarawneh M; Ismail K Curr Probl Cardiol; 2024 Mar; 49(3):102399. PubMed ID: 38242265 [TBL] [Abstract][Full Text] [Related]
11. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732 [TBL] [Abstract][Full Text] [Related]
12. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States. Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577 [TBL] [Abstract][Full Text] [Related]
13. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542 [TBL] [Abstract][Full Text] [Related]
14. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267 [TBL] [Abstract][Full Text] [Related]
15. United States women receive more curative treatment for hepatocellular carcinoma than men. Cauble S; Abbas A; Balart L; Bazzano L; Medvedev S; Shores N Dig Dis Sci; 2013 Oct; 58(10):2817-25. PubMed ID: 23812858 [TBL] [Abstract][Full Text] [Related]
16. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365 [TBL] [Abstract][Full Text] [Related]
17. Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient Samples. Zhang SS; Zhang JF; Wang JQ; Tang J; Wu ZL; Huang J; Xue J Curr Med Sci; 2023 Jun; 43(3):520-525. PubMed ID: 37115395 [TBL] [Abstract][Full Text] [Related]
18. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation. Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408 [TBL] [Abstract][Full Text] [Related]
19. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma. Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336 [TBL] [Abstract][Full Text] [Related]
20. Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C. Kangas-Dick A; Gall V; Hilden P; Turner A; Greenbaum A; Sesti J; Paul S; Carpizo D; Kennedy T; Sadaria Grandhi M; Alexander HR; Wang S; Geffner S; August D; Langan RC Surgery; 2020 Jul; 168(1):49-55. PubMed ID: 32414566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]